Prolonged or excessive formation and liberation of cytotoxic substances from neutrophils intensifies inflammation and the risk of tissue damage. From this perspective, administration of substances which are able to reduce activity of neutrophils and to enhance apoptosis of these cells may improve the therapy of pathological states connected with persistent inflammation. In this short review, neutrophil oxidative burst and apoptosis are presented as potential targets for pharmacological intervention. Effects of natural polyphenols (resveratrol, pterostilbene, pinosylvin, piceatannol, curcumin, N-feruloylserotonin) are summarised, considering the ability of these compounds to affect inflammation and particularly neutrophil activity. The intended neutrophil inhibition is introduced as a part of a new strategy for pharmacological modulation of chronic inflammatory processes, focused on supporting innate antiinflammatory mechanisms and enhancing resolution of inflammation.
to cellular dysfunction, tissue damage and to persisting inflammation. Moreover, defective regulation is thought to participate in the pathogenesis of chronic inflammatory diseases, such as asthma, rheumatoid arthritis or chronic obstructive pulmonary disease. Therefore the novel strategy of anti-inflammatory therapy is based upon pharmacological agents capable to enhance the resolution of inflammation (Sawatzky et al., 2006; Serhan et al., 2007; Hallett et al., 2008) . Several drugs were found to promote pro-resolution pathways, such as aspirin (stimulates formation of lipoxins), glucocorticoids (activate macrophages and accelerate apoptosis of eosinophils), methotrexate (increases synthesis of endogenous anti-inflammatory mediators), as well as substances modulating neutrophil activity and apoptosis (Yasui & Baba, 2006; Rossi et al., 2007; Filep & El Kebir, 2009 ).
Pro-infl ammatory activity of neutrophils
Neutrophils (neutrophilic polymorphonuclear leukocytes) represent the body's primary line of defense against invading pathogens. Nevertheless, recently they New strategy for pharmacological modulation of infl ammatory processes Resolution (i. e. termination of the defense/beneficial inflammation) has historically been viewed as a passive process, occurring as a result of withdrawal of proinflammatory signals. Thus most anti-inflammatory drugs in use suppress mechanisms engaged at the onset and progression of inflammation, but they are not targeted to support natural anti-inflammatory reactions. Only recently has the concept been established that resolution is an active process with a distinct set of chemical mediators (lipoxins, resolvins, protectins), involving decrease in activities of neutrophils and eosinophils, programmed death (apoptosis) of these cells, as well as their clearance from the site of inflammation by macrophages (Kohli & Levy, 2009; Serhan et al., 2007 Serhan et al., , 2008 ). An abnormal, ineffective or absent regulation of these processes contributes have been increasingly studied as active participants in the initiation and progression of many pathological states, such as rheumatoid polyarthritis, carcinoma, allergy or ischaemia-reperfusion. All these conditions are generally accompanied by dysregulated, persistent and excessive activation of neutrophils, resulting in damage of adjacent tissues by neutrophil "destructive hardware" -by reactive oxygen species, cytotoxic proteins and proteolytic enzymes (Cascao et al., 2009 (Cascao et al., , 2010 Fialkow et al., 2007; Wright et al., 2010) . In rheumatoid arthritis, neutrophil derived oxidants can induce cartilage degradation, depolymerise hyaluronan and decrease its lubricative properties. Further they can reduce the protective antioxidant and antiproteinase capacity of synovial fluid and thus participate in joint erosion (Cascao et al., 2009; Edwards & Hallett, 1997) . Besides, neutrophils are capable to release inflammatory mediators (eicosanoids, chemokines, cytokines), which along with their altered recruitment and delayed apoptosis, have the potential to maintain permanent inflammation (Cascao et al., 2010; Wright et al., 2010) . The treatment of diseases associated with chronic inflammation should thus be focused also on neutrophil functions; formation of reactive oxygen intermediates and apoptosis of these cells represent two promising targets for pharmacological intervention.
Formation of reactive oxygen species
Reactive oxygen species (ROS) are produced in large quantities when neutrophils are stimulated by proinflammatory agents or by particles such as bacteria. This process, known as "oxidative burst", is initiated by the activation of NADPH oxidase (NADPH: nicotine amide adenine dinucleotide phosphate). During this process, the cytosolic phox proteins (phox: phagocyte oxidase) p47 phox , p67 phox , p40 phox and Rac2 translocate to the plasma membrane or to membranes of specific granules, where they associate with the membrane-bound components (p22 phox , gp91 phox ) to assemble the catalytically active oxidase (El-Benna et al., 2010; Ambruso et al., 2004) . A partial association of NADPH oxidase components was observed in neutrophils primed with TNFα, GM-CSF or LPS. This configuration, not sufficient for ROS generation, amplifies the oxidative burst initiated by subsequent stimulation of neutrophils (Sheppard et al., 2005) .
Activated NADPH oxidase transfers an electron from NADPH to molecular oxygen, generating superoxide anion. This precursor of other ROS is immediately transformed into hydrogen peroxide (H 2 O 2 ), spontaneously or through enzymatic dismutation by superoxide dismutase. Interaction between H 2 O 2 and superoxide anion can give rise to the hydroxyl radical, one of the most powerful oxidants. Moreover, hydrogen peroxide is a substrate of myeloperoxidase, which catalyses its transformation into highly toxic molecules such as hypochlorous acid, chloramines and tyrosyl radicals (El-Benna et al., 2010; Robinson, 2009 ). The percentage of particular oxygen metabolites was found to be dependent on the mechanism of neutrophil activation (Takahashi et al., 1991) .
Activated neutrophils form and liberate reactive oxygen species both extra-and intracellularly (El-Benna et al., 2010; Karlsson & Dahlgren, 2002) . Oxidative burst arising inside neutrophils is much less pronounced and reaches maximum values later than the external ROS formation. The intracellular oxidants fulfill a regulatory role and participate in the initiation of neutrophil apoptosis (Luo & Loison, 2008; Witko-Sarsat et al., 2011) . The substantial part of reactive oxygen species is formed at neutrophil plasma membranes and is liberated extracellularly or into phagosomes. These radicals are involved in the elimination of pathogens, however their overproduction may result in damage of surrounding tissues. Confirmation of the destructive role of radicals in pathological states associated with persistent inflammation (Halliwell & Whiteman, 2004; Lonkar & Dedon, 2011) initiated an intensive search for substances with antioxidant activity. Since the optimum therapy is expected to minimise tissue damage without reduction of the physiological function of neutrophils, separate analysis of extra-and intracellular effects of antioxidants is of particular importance. The chemiluminescence method, based on different abilities of luminol and isoluminol to cross biological membranes and to interact with radicals inside cells, represents an effective tool for such differentiation (Drábiková et al., 2006; .
Neutrophil apoptosis
Apoptosis is a complex physiological mechanism in which a cell undergoes programmed death as a result of withdrawal of survival factors and/or of exposure to pro-apoptotic signals. It represents a sensitive and highly regulated process (Box 1), which includes mitochondrial membrane permeabilisation, followed by the release of cytochrome c and other pro-apoptotic proteins into the cytosol, gradual activation of caspases, DNA fragmentation, chromatin condensation, loss of membrane asymmetry and formation of apoptotic bodies. In contrast to necrosis, apoptosis saves the integrity of neutrophil membranes and prevents the discharge of cytotoxic and proteolytic contents into the surrounding tissues (Luo & Loison, 2008; Witko-Sarsat et al., 2011; Hallett et al., 2008) . Alterations in plasma membrane (e.g. externalisation of phosphatidylserine) facilitate the recognition and clearance of apoptotic neutrophils by macrophages, resulting in safe removal of these cells from the site of inflammation. Moreover, on recognising apoptotic neutrophils, macrophages are programmed to upregulate the production of anti-inflammatory mediators such as transforming growth factor (TGF)-β and interleukin (IL)-10, resulting in reduction of the inflammatory process (Duffin et al., 2010; Nussbaum & Shapira, 2011) . Due to these facts, better comprehension of neutrophil apoptosis might lead to novel therapeutic strategies designed to enhance resolution of inflammation without tissue damage (Witko-Sarsat et al., 2011) . At present, a great deal of substances directing neutrophils to apoptosis are tested in vitro as well as under conditions of experimental inflammation (Hallett et al., 2008; Hu et al., 2005; Sawatzky et al., 2006; Derouet et al., 2006; Serhan et al., 2007; Jagetia & Aggarwal, 2007) . The most intensively examined substances have been inhibitors of nuclear factor-κB, compounds modifying the expression of pro-and anti-apoptotic Bcl-2 (B-cell lymphoma-2) proteins or PI3K (phosphoinositide-3-kinase) and CDK (cycline-dependent kinase) inhibitors.
Neutrophils as potential targets for pharmacological intervention
Prolonged or excessive formation and liberation of cytotoxic substances from neutrophils, accompanied by delayed apoptosis of these cells, intensify inflammation and the risk of tissue damage (Figure 1 perspective, the pharmacological intervention capable to enhance the resolution of inflammation through modulation of its important inputs -activity and apoptosis of neutrophils -represents a prospective alternative. To date, the intended neutrophil inhibition has not been involved in the therapy of pathological states connected with persistent inflammation. Since this therapy is long-lasting and often accompanied with many adverse reactions, co-application of substances which are able to reduce the activity of neutrophils and/or to enhance apoptosis of these cells may lead to its increased effectiveness and reduced toxicity. In this regard, the group of natural polyphenols could provide appropriate candidates for such a combined therapy. 
Compound References
Resveratrol inflammatory biomarkers (e.g. TNFα, 5-lipoxygenase, COX-1, COX-2, TXB 2 , iNOS, CRP), expression of angiogenic and metastatic gene products (e.g. MMPs, VEGF, cathepsin D, and ICAM-1), activity protein kinases (e.g. src, PI3K, JNK, and AKT), expression of antiapoptotic gene products (e.g. Bcl-2, Bcl-X L , XIAP and survivin), adenosine nucleotide secretion from activated platelets, IL-8, GM-CSF, activation of NF-κB, antioxidant enzymes (e.g. catalase, superoxide dismutase and hemoxygenase-1), antioxidant activity
Alarcón de la Lastra & Villegas, 2005; Haricumar & Aggarwal, 2008; Pterostilbene activation of NF-κB, COX-1, COX-2, iNOS production of pro-inflammatory mediators (PGE 2 , TNFα), antioxidant activity Perečko et al., 2010; Cichocki et al., 2008; Remsberg et al., 2008; Paul et al., 2009; ; Pinosylvin antioxidant activity, activation of NF-κB, production of pro-inflammatory mediators, COX-2 and iNOS expression Roupe et al., 2006; Lee et al., 2006; Park et al., 2005; Park et al., 2011 Piceatannol Syk, COX-2, iNOS, antioxidant activity, MPO, PGE 2 , pro-inflammatory cytokines Roupe et al., 2006; Son et al., 2010; Kim et al., 2008 Curcumin activation of NF-κB, overexpression of inflammatory cytokines and adhesion molecules, activity of COX-2, iNOS and LOX, antioxidant activity Jurenka, 2009; Srivastava et al., 2011; Aggarwal & Sung, 2009 N-feruloyl serotonin antioxidant activity, LDL oxidation, activation of caspase-3, ROS-dependent adhesion, migration of monocytes to endothelial cells, activation of NF-κB Piga et al., 2009; Piga et al., 2010 Abbreviations Srivastava et al., 2011; Jančinová et al., 2009; Jančinová et al., 2011; Prasad et al., 2004 N-feruloyl serotonin ROS production, protein kinase C activation Nosáľ et al., 2011; Nosáľ et al., 2010 Abbreviations used: see Table 1 . 
Natural polyphenols and their eff ects on neutrophils
Phenolic compounds of plant origin integrate a large group of plant secondary metabolites with remarkably rich structural variations. They are generally characterised as aromatic compounds, possessing one or more hydroxyls attached directly to the aromatic (phenolic) moiety of the molecule. The most common types of plant phenols involve phenolic acids, coumarins, stilbenes, flavonoids, lignans, condensed tannins and lignins . In this review, effects of two derivatives of ferulic acid (curcumin, N-feruloylserotonin) and four stilbenes (resveratrol, pterostilbene, pinosylvin, piceatannol) are summarised, considering the ability of these compounds to affect inflammation and particularly neutrophil activity. Besides their broad structural variability, natural polyphenols are characterised by a great variety of biological effects. Beneficial anti-inflammatory activities, most completely examined for resveratrol and curcumin (Table 1) , have been attributed to the capacity of plant phenols to prevent activation of nuclear factor-kappa B and the subsequent overexpression of pro-inflammatory mediators -cytokines, adhesion molecules, cyclooxygenase-2, 5-lipoxygenase, myeloperoxidase or inducible nitric oxide synthase. Minor attention has been concentrated on the effect of polyphenols on the activity of neutrophils ( Table 2 ). The existing results suggest that plant polyphenols can control neutrophil activity by multiple mechanisms and therefore may be more efficient than synthetic inhibitors directed against one particular enzyme or receptor (Burgos et al., 2009) .
